ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.

March 26, 2004

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

In Brief: NCI Authorization Should be $1.3 Billion, Humphrey Tells Kennedy; GOG Gets New Life

March 3, 1978

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983